首页> 外文期刊>European urology >Hyponatremia associated with worse outcomes in metastatic renal cell cancer: A potential target for intervention?
【24h】

Hyponatremia associated with worse outcomes in metastatic renal cell cancer: A potential target for intervention?

机译:转移性肾细胞癌中较差的迟发性癌症:潜在的干预目标?

获取原文
获取原文并翻译 | 示例
           

摘要

There has been great interest in the prognostic and predictive value of low serum sodium levels since hyponatremia was found to be associated with poor survival in numerous medical conditions such as heart failure and stroke, as well as several solid organ malignancies [1 ]. Hyponatremia has also been implicated in localized renal cell carcinoma (RCC) [2], with two small studies confirming its prognostic value in the metastatic setting [1,3].
机译:由于发现低血清血症在心力衰竭和中风(如心力衰竭和中风)中的许多医疗病症中的存活率差,以及几种固体器官恶性肿瘤[1],对低血清钠水平的预后和预测值具有很大的兴趣。 低钠血症也涉及局部肾细胞癌(RCC)[2],具有两个小型研究,证实了转移凝固中的预后值[1,3]。

著录项

  • 来源
    《European urology》 |2014年第4期|共2页
  • 作者

    BellmuntJ.; LeowJ.J.;

  • 作者单位

    Bladder Cancer Center Dana-Farber/Brigham and Women's Cancer Center Harvard Medical School;

    Bladder Cancer Center Dana-Farber/Brigham and Women's Cancer Center Harvard Medical School;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 泌尿科学(泌尿生殖系疾病);
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号